Your browser doesn't support javascript.
loading
Feelings of depression, pain and walking difficulties have the largest impact on the quality of life of people with multiple sclerosis, irrespective of clinical phenotype.
Zhang, Yan; Taylor, Bruce V; Simpson, Steve; Blizzard, Leigh; Campbell, Julie A; Palmer, Andrew J; van der Mei, Ingrid.
Afiliação
  • Zhang Y; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
  • Taylor BV; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
  • Simpson S; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia/Melbourne School of Population & Global Health, The University of Melbourne, Melbourne, VIC, Australia.
  • Blizzard L; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
  • Campbell JA; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
  • Palmer AJ; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia/Melbourne School of Population & Global Health, The University of Melbourne, Melbourne, VIC, Australia.
  • van der Mei I; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Mult Scler ; 27(8): 1262-1275, 2021 07.
Article em En | MEDLINE | ID: mdl-32924841
ABSTRACT

BACKGROUND:

The symptoms that have the largest impact on health-related quality of life (HRQoL) in people with multiple sclerosis (MS) may vary by MS phenotype (relapsing-remitting MS (RRMS), secondary progressive MS (SPMS) and primary progressive MS (PPMS)). Knowing these symptoms assists in symptom management.

OBJECTIVE:

To examine the associations between 13 common MS symptoms and HRQoL in the total sample and stratified by MS phenotype.

METHOD:

The study included 1985 participants. HRQoL was measured with two multi-attribute utility instruments assessment of quality of life with eight dimensions (AQoL-8D) and European quality of life with five dimensions and five levels for each dimension (EQ-5D-5L). Multivariable linear regression was used to identify the symptoms that had the largest impact on the HRQoLs.

RESULTS:

Feelings of depression, pain, fatigue, and feelings of anxiety were most strongly associated with AQoL-8D and EQ-5D-5L. Walking difficulties additionally contributed to reduced EQ-5D-5L. The strongest single predictors in the multivariable analyses were feelings of depression or pain for AQoL-8D and walking difficulties for EQ-5D-5L, irrespective of MS phenotype.

CONCLUSION:

The strongest single predictors for the AQoL-8D and EQ-5D-5L were feelings of depression, pain and walking difficulties, irrespective of MS phenotype. Reducing these symptoms may have the largest impact on improving HRQoL in all MS phenotypes of people with MS.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Esclerose Múltipla Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Esclerose Múltipla Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália